ERC Consolidator Grant · 2019
Recent investigations revealed that cancer tissue possesses several important metabolic features, such as differential utilization of many essential metabolites. This phenomenon is now referred to as "metabolic reprogramming" and is known to be required for malignant transformation, tumor development, invasion and metastasis. Its complex and dynamic nature has been recognized as one of the major challenges for effective cancer treatment. Therefore, a better understanding of metabolic dependencies in specific tumor types can provide a path for improved cancer treatments. However, no efficient methodologies currently exist that allow noninvasive imaging and quantification of the uptake of…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.